HKEX:8329 - Shenzhen Neptunus Interlong Bio-Technique Co Ltd Shenzhen Neptunus Interlong Bi
Sector: Health Care, Industry: Pharmaceuticals
Next Earnings: 6 May 2024
Add to Watchlist
   
Add Alert 


Yahoo Finance (Live Price)

HKD 0.155    +0.004 (+2.65%)

23 Apr 2024


Loading...
Loading...
Loading...

General

CEO: Mr. Feng Zhang

IPO: 2005-09-12

Headquarters: HK

Employees: 1,444

Homepage

Description

Shenzhen Neptunus Interlong Bio-Technique Co Ltd is engaged in the research and development, manufacturing and selling of medicines and medical devices. It is also involved in the purchase and sales of medicines and healthcare food products. The group's revenue and results from operations are mainly derived from activities in the PRC. The operating segments of the company are Manufacturing and selling of medicines; nd the Sales and distribution of medicines and healthcare products. Majority of revenue is generated from Manufacturing and selling of medicines.

Your Holdings
Dashboard
Portfolio
Options

Tools
Screener
Watchlist
Alerts
Notes
Community
Forum
Blog
YouTube
Shared Portfolios
Shared Screeners

Collab with Brokerages
Moomoo x StocksCafe
Tiger x StocksCafe

Help
Quickstart Guides
StocksCafe Academy
StocksCafe Youtube Channel

About StocksCafe
Our Story
Send Feedback
Pricing
Market
Singapore
Hong Kong
Tokyo
Kuala Lumpur
United States
London
Shenzhen
Shanghai
Bombay
National (India)
Indexes
Singapore Savings Bonds
Singapore T-Bills
CoinGecko
Your Account
Settings
Subscriptions
Referrals
Messages
Profile
YouTube
Server T1

About · FAQs · StocksCafe © 2024 · Privacy · Terms